Market, Research, Report, Business, Industry, Information, Automotive, Banking, Finance, Food, Beverages, Technology, Biomass, Books, Conference, Company Profiles, Country

 
 
   Aarkstore.com | Your Comprehensive Resource For Market Research
    Your Comprehensive Resource
 For Market Research

   
   
 Home  Contact us

 Login



Search for Industry Sector, Market Sector, Company Profiles

  

   

        

 Follow Us !!!

 
 
   

CombinatoRx, Incorporated - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Request for Sample Pages
Published Date : 1 July 2009
Pages : 19
 Add to Cart - CombinatoRx, Incorporated - Pharmaceuticals & Healthcare - Deals and Alliances Profile 
 
Summary

CombinatoRx, Incorporated (CombinatoRx) is a biopharmaceutical company engaged in developing synergistic combinations pharmaceuticals. The company currently has a portfolio of products in the 2nd phase clinical trials associated with the treatment of rheumatoid arthritis, psoriasis, atopic dermatitis, Type-2 diabetes and asthma. The company is headquartered in Cambridge, United States

 CombinatoRx, Incorporated - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick “one-stop-shop” to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company."
 

Table of Contents :
List of Tables 3
List of Figures 3
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 7
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare, Deal Details 9
Equity Offering 9
CombinatoRx announces closing of $48 million private placement 9
CombinatoRx Completes Initial Public Offering Of $48.3 Million 10
Partnerships 11
Angiotech Extends Collaboration Agreement With CombinatoRx 11
CombinatoRx Signs An Agreement With Cystic Fibrosis 12
CombinatoRx Signs Agreement With Fovea Pharmaceuticals 13
CombinatoRx Signs An Agreement With Angiotech Pharmaceuticals 14
CombinatoRx Enters Into Agreement With HenKan Pharmaceutical 15
Venture Financing 16
CombinatoRx Secures $30 Million In Third Round Of Financing 16
Key Competitors 17
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About Global Markets Direct 19
Contact Us 19
Disclaimer 19

List of Tables
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
CombinatoRx, Incorporated, Deals By Sector, 2004 to YTD 2009 7
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
CombinatoRx announces closing of $48 million private placement 9
CombinatoRx Completes Initial Public Offering Of $48.3 Million 10
Angiotech Extends Collaboration Agreement With CombinatoRx 11
CombinatoRx Signs An Agreement With Cystic Fibrosis 12
CombinatoRx Signs Agreement With Fovea Pharmaceuticals 13
CombinatoRx Signs An Agreement With Angiotech Pharmaceuticals 14
CombinatoRx Enters Into Agreement With HenKan Pharmaceutical 15
CombinatoRx Secures $30 Million In Third Round Of Financing 16
CombinatoRx, Incorporated, Key Employees 17
CombinatoRx, Incorporated, Subsidiaries 18

List of Figures
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 5
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
CombinatoRx, Incorporated, Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 7"
 
 

Published By : Global Markets Direct

 


Category Related Report: Automotive, Automobile, Aerospace & Aviation, Banking, Consumer Goods, Construction, Chemicals, Defense, Diabetes, Disease, Drinks, Energy, Electronics, Financial , Food & Drinks, Glass, Healthcare, Insurance, Information technology, Investment, Industrial Gases, Industry Profile, Medical, Media, Marketing, Miscellaneous, Metals & Mining, Nuclear Energy, Oil & Gas, Power, Real Estate, Software, Solar, Transportation

  

 


PDF Format Reports will be
delivered by email within
12 to 24 hours after placing
 the order (Mon-Fri IST)

Australia Research Reports
Brazil Research Reports
Asia Research Reports
China Research Reports
Canada Research Reports
Europe Research Reports
France Research Reports
Egypt Research Reports
Global Research Reports
Greece Research Reports
Germany Research Reports
Japan Research Reports
India Research Reports
Ireland Research Reports

Korea Research Reports
Mexico Research Reports

Maldives Research Reports
New Zealand Research Reports
Netherland Research Reports
Poland Research Reports
Russia Research Reports
South Africa Research Reports
Sri Lanka Research Reports

Singapore Research Reports
Switzerland Research Reports  
UK Research Reports
USA Research Reports

UAE Research Reports
Uruguay Research Reports

ExxonMobil Company Analysis
Toyota Motors Company Analysis
ConocoPhillips Company Analysis
Sinopec Company Analysis
Total S.A. Company Analysis
Verizon Company Analysis
Gazprom Company Analysis
JPMorgan Company Analysis
Chevron Company Analysis
E.ON Company Analysis
PetroChina
Company Analysis
Allianz Company Analysis
AXA Company Analysis
Carrefour
Company Analysis
General Electric Company Analysis
Bank of America Company
Assicurazioni Generali Company
Samsung Electronics Company
GDF Suez Company Analysis
McKesson Corporation Company
Volkswagen Group Company
Royal Dutch Shell Company
 


 

 
 

Privacy Policy | Help/FAQ | Disclaimer | Sitemap | Resources | Research Blog |Blog | |

Copyright © 2008 - 2012  trademark registered in India. All rights reserved.
Office Phone: (+91)
2227453309 | Telefax No: (+91) 2224169996
24/7 Online Support: (+91) 8149 85 2585 | Publishers contact: (+91) 8080 85 2585
Office Hours: 10:00 am to 6:00 pm (IST) Monday to Saturday

Email:
contact@aarkstore.com / customersupport@aarkstore.com